Hepatopancreatic biliary malignancy
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Known or suspected cholagiocellular carcinoma, gallbladder carcinoma, bile duct carcinoma pancreatic cancer. 2. Patients without distant metastases, undergoing curative resection 3. Included patients undergoing PTBD, or ENBD. 4. Operable general condition 5. Written informed consent
Exclusion criteria
Exclusion criteria: 1. Severe drug allergy including contrast medium, severe asthma, renal failure 2. Patinets who underwent previously were exludud from a comparative study. 3. Patiners with hepatocellular carcinoma and massforming type cholangiocarcinoma
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| sensitivity, specificity | — |
Secondary
| Measure | Time frame |
|---|---|
| positive predictive value, prediction of prevalence of disease | — |
Countries
Japan
Contacts
National Cancer Center Hospital Division of Hepatobiliary and pancreatic surgery